Ensembl Scientific Advisory Board

The Ensembl project receives advice and guidance from our scientific advisory board. The Ensembl SAB consists of a collection of scientists representing a spread of disciplines across and beyond biology. Our current SAB members are:

• Wendy Bickmore, Director, MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, UK
• Max Haussler, Associate Research Scientist, UCSC Santa Cruz, USA
• Nils Gehlenborg, Assistant Professor of Biomedical Informatics, Harvard Medical School, Boston, USA
• Martien Groenen, Professor in Animal Genomics, Wageningen University, The Netherlands
• Tomàs Marquès Bonet, ICREA Research Professor, Institut de Biologia Evolutiva, Barcelona, Spain
• Monica Poelchau, Geneticist, National Agricultural Laboratory, Colorado, USA
• Heidi Rehm, Chief Genomics Officer, Center for Genomic Medicine and Department of Medicine at Massachusetts General Hospital, USA
• Emma Teeling, Full Professor School of Biology and Environmental Science, University College Dublin, Ireland

We thank the previous members of the Ensembl SAB for their contributions to the project.

• Mark Diekhans, Technical Project Manager, Center for Biomolecular Science & Engineering, UCSC, California, USA
• Deanna Church, Senior Director of Applications, 10x Genomics, California, USA
• Erich Jarvis, Investigator, Howard Hughes Medical Institute, Professor, Laboratory of Neurogenetics of Language, the Rockefeller University, New York, USA
• Federica Di Palma, Director of Science (Vertebrate and Health Genomics), The Genome Analysis Centre, Norwich, UK
• Felicity Jones, Max Planck Research Group Leader, Friedrich Miescher Laboratory, Tuebingen, Germany
• Allan Bradley, Wellcome Trust Sanger Institute
• Anne Ferguson-Smith, University of Cambridge
• Ian Bird, CERN
• Jim Reecy, Iowa State University
• Bob Kuhn, University of California, Associate Director, UCSC Genome Browser, Santa Cruz
• Chris Ponting, Department of Human Anatomy and Genetics, Oxford University
• Cornelius Gross, Deputy Head of Outstation and Senior Scientist, EMBL Monterotondo
• David Botstein, Princeton University
• David Haussler, University of California Santa Cruz
• Deepak Singh, Business Development Manager, Amazon Web Services, Seattle
• Detlev Arendt, European Molecular Biology Laboratory
• Graham Cameron, Deputy Director, EMBL-EBI
• Hugues Roest Crollius, Ecole Normale Supérieure, Paris, France
• Ivo Gut, Centro Nacional de Análisis Genómico, Spain
• Jim Kent, University of California Santa Cruz
• Johan den Dunnen, Leiden University Medical Center, The Netherlands
• Lincoln Stein, Cold Spring Harbor Laboratory
• Mark McCarthy, Oxford Centre for Diabetes, Oxford University
• Matt Hurles, Genomic mutation and genetic disease, Wellcome Trust Sanger Institute, Hinxton, UK
• Matthias Hentze, EMBL-Heidelberg
• Michael Ashburner, Department of Genetics, University of Cambridge
• Michael Dunn, Wellcome Trust
• Michelle Clamp, BioTeam, Boston
• Mike Eisen, University of California, Berkeley
• Mike Stratton, Director, WTSI
• Nicholas A. Walton, Institute of Astronomy, University of Cambridge
• Soren Brunak, Technical University of Denmark
• Stephan Beck, University College London
• Steve Cohen, EMBL-Heidelberg
• Toby Bloom, Director of Informatics, Broad Institute of MIT and Harvard, Boston, Massachusetts, USA